Unveiling sarcopenia prevalence in post-cancer patients: Integrating functional and morphological assessments for accurate diagnosis
Sarcopenia is highly prevalent in post-cancer patients including younger individuals and those in long-term remission. The 2019 EWGSOP2 criteria, combining ALM and functional tests, effectively identified sarcopenia but screening with SARC-F may not be suitable in the post-cancer population.
Authors
- Alexandre Foncelle (ORCID: https://orcid.org/0000-0002-4679-6601)
- Marine Gaudé
- Sophie Courtois (ORCID: https://orcid.org/0000-0002-3213-6418)
- M. Seauve
- Benjamin Laurent
- Emmanuel Massy (ORCID: https://orcid.org/0000-0002-4842-8618)
- Laure Christophe
- Mélanie Auréal (ORCID: https://orcid.org/0000-0001-6905-8735)
- Cyrille B. Confavreux (ORCID: https://orcid.org/0000-0002-9318-6785)
- Justine Bérardet
- Marie Meunier
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Centre de Recherche en Neurosciences de Lyon (FR)
- Hospices Civils de Lyon (FR)
- Centre de Recherche en Cancérologie de Lyon (FR)
Publication Details
- Journal
- Joint Bone Spine
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1016/j.jbspin.2025.106022
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00